Search research articles
Contact Us
Filters
Showing results (61-70 of 198) with videos related to
Page
of 20
Sort By:
Oncotarget
|
November 6, 2015
Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer
Jakob Schöttle, Sampurna Chatterjee, Caroline Volz, et al.
The Journal of Clinical Investigation
|
March 5, 2013
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
Sampurna Chatterjee, Lukas C Heukamp, Maike Siobal, et al.
International Journal of Cancer
|
November 19, 2013
The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma
Achim Rothe, Ron D Jachimowicz, Sven Borchmann, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2022
Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors
Sven Borchmann, Carolin Selenz, Mia Lohmann, et al.
Cancer Research
|
May 20, 2018
Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer
Lydia Meder, Philipp Schuldt, Martin Thelen, et al.
JCI Insight
|
May 22, 2024
Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis
Lydia Meder, Charlotte Isabelle Orschel, Christoph Julius Otto, et al.
Molecular Cell
|
May 1, 2018
HMGB2 Loss upon Senescence Entry Disrupts Genomic Organization and Induces CTCF Clustering across Cell Types
Anne Zirkel, Milos Nikolic, Konstantinos Sofiadis, et al.
Science Translational Medicine
|
July 6, 2012
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice
Lukas C Heukamp, Theresa Thor, Alexander Schramm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2011
Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography
Thomas Zander, Matthias Scheffler, Lucia Nogova, et al.
Cell Reports
|
April 30, 2020
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC
Caroline Volz, Sara Breid, Carolin Selenz, et al.
Page
of 20
Search research articles
Search
Showing results (61-70 of 198) with videos related to
Sort By:
Page
of 20
Oncotarget
|
November 6, 2015
Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer
Jakob Schöttle, Sampurna Chatterjee, Caroline Volz, et al.
The Journal of Clinical Investigation
|
March 5, 2013
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
Sampurna Chatterjee, Lukas C Heukamp, Maike Siobal, et al.
International Journal of Cancer
|
November 19, 2013
The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma
Achim Rothe, Ron D Jachimowicz, Sven Borchmann, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2022
Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors
Sven Borchmann, Carolin Selenz, Mia Lohmann, et al.
Cancer Research
|
May 20, 2018
Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer
Lydia Meder, Philipp Schuldt, Martin Thelen, et al.
JCI Insight
|
May 22, 2024
Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis
Lydia Meder, Charlotte Isabelle Orschel, Christoph Julius Otto, et al.
Molecular Cell
|
May 1, 2018
HMGB2 Loss upon Senescence Entry Disrupts Genomic Organization and Induces CTCF Clustering across Cell Types
Anne Zirkel, Milos Nikolic, Konstantinos Sofiadis, et al.
Science Translational Medicine
|
July 6, 2012
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice
Lukas C Heukamp, Theresa Thor, Alexander Schramm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2011
Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography
Thomas Zander, Matthias Scheffler, Lucia Nogova, et al.
Cell Reports
|
April 30, 2020
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC
Caroline Volz, Sara Breid, Carolin Selenz, et al.
Page
of 20